| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Koumi Miyasaka, Sakiko Hirofuji, Mika Maezawa, Satoshi Nakao, Moe Yamashita, Nanaka Ichihara, Yuka Nokura, Hirofumi Tamaki, Kazuhiro Iguchi, Mitsuhiro Nakamur. Evaluation of Antipsychotic-Induced Neuroleptic Malignant Syndrome Using a Self-Organizing Map. Cureus. vol 16. issue 8. 2024-10-01. PMID:39350836. |
the numbers of cases of nms (smq code: 20000044) reported for risperidone, aripiprazole, haloperidol, olanzapine, and quetiapine were 1691, 1294, 1132, 1056, and 986, respectively. |
2024-10-01 |
2024-10-03 |
Not clear |
| Khasan Ibragimov, Gregory Peter Keane, Cristina Carreño Glaría, Jie Cheng, Augusto Eduardo Llos. Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders. The Cochrane database of systematic reviews. vol 7. 2024-07-03. PMID:38958149. |
haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders. |
2024-07-03 |
2024-07-06 |
Not clear |
| Bálint Jezsó, Sára Kálmán, Kiara Gitta Farkas, Edit Hathy, Katalin Vincze, Dzsenifer Kovács-Schoblocher, Julianna Lilienberg, Csongor Tordai, Zsófia Nemoda, László Homolya, Ágota Apáti, János M Réthely. Haloperidol, Olanzapine, and Risperidone Induce Morphological Changes in an In Vitro Model of Human Hippocampal Neurogenesis. Biomolecules. vol 14. issue 6. 2024-06-27. PMID:38927091. |
haloperidol, olanzapine, and risperidone induce morphological changes in an in vitro model of human hippocampal neurogenesis. |
2024-06-27 |
2024-06-29 |
human |
| Kanako Ishizuka, Toshiya Inad. A systematic review and network meta-analysis of antimanic drugs for the treatment of acute mania used in Japan. PCN reports : psychiatry and clinical neurosciences. vol 1. issue 4. 2024-06-13. PMID:38868658. |
a literature search was conducted using the medline, pubmed, and ichushi databases from their dates of inception to july 31, 2021, for studies written in english or japanese with a primary diagnosis of bipolar i disorder, comparing any of the following active drugs to treat acute mania in adults: aripiprazole, carbamazepine, chlorpromazine, haloperidol, lithium, olanzapine, sultopride, timiperone, and zotepine. |
2024-06-13 |
2024-06-15 |
human |
| Mingwei Gao, Fuqi Wang, Chuanyao Sun, Shuzhuo Zhang, Ruibin S. Effects of olanzapine on hippocampal CA3 and the prefrontal cortex local field potentials. European journal of pharmacology. 2024-02-07. PMID:38325793. |
olanzapine is an antipsychotic drug applied in psychiatry to treat psychoses, especially schizophrenia and schizoaffective disorders with similar or better improvement than haloperidol and risperidone in the treatment of depressive and negative symptoms. |
2024-02-07 |
2024-02-10 |
Not clear |
| Jana Osacka, Alexander Kiss, Zuzana Bacova, Andrej Tillinge. Effects of antipsychotics, haloperidol and olanzapine, on the expression of apoptosis-related genes in mouse mHippoE-2 cells and rat hippocampus. Endocrine regulations. vol 57. issue 1. 2023-08-10. PMID:37561834. |
effects of antipsychotics, haloperidol and olanzapine, on the expression of apoptosis-related genes in mouse mhippoe-2 cells and rat hippocampus. |
2023-08-10 |
2023-08-16 |
mouse |
| Sanja Strbe, Ivan Maria Smoday, Ivan Krezic, Luka Kalogjera, Vlasta Vukovic, Helena Zizek, Slaven Gojkovic, Hrvoje Vranes, Ivan Barisic, Suncana Sikiric, Marijan Tepes, Katarina Oroz, Filip Brkic, Martin Drinkovic, Lidija Beketic Oreskovic, Jelena Popic, Alenka Boban Blagaic, Anita Skrtic, Mario Staresinic, Sven Seiwerth, Predrag Sikiri. Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as Therapy. Pharmaceuticals (Basel, Switzerland). vol 16. issue 6. 2023-06-28. PMID:37375736. |
in rats with complete calvariectomy, medication (bpc 157 10 µg/kg, 10 ng/kg ip or ig) was given 5 min after distinctive dopamine agents (mg/kg ip) (haloperidol (5), fluphenazine (5), clozapine (10), risperidone (5), olanzapine (10), quetiapine (10), or aripiprazole (10), domperidone (25), amphetamine (10), and combined amphetamine and haloperidol) and assessed at 15 min thereafter. |
2023-06-28 |
2023-08-14 |
rat |
| Stefan Leucht, Johannes Schneider-Thoma, Angelika Burschinski, Natalie Peter, Dongfang Wang, Shimeng Dong, Maximilian Huhn, Adriani Nikolakopoulou, Georgia Salanti, John M Davi. Long-term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network meta-analysis. World psychiatry : official journal of the World Psychiatric Association (WPA). vol 22. issue 2. 2023-05-10. PMID:37159349. |
in terms of overall symptoms, olanzapine was on average more efficacious than ziprasidone (standardized mean difference, smd=0.37, 95% ci: 0.26-0.49), asenapine (smd=0.33, 95% ci: 0.21-0.45), iloperidone (smd=0.32, 95% ci: 0.15-0.49), paliperidone (smd=0.28, 95% ci: 0.11-0.44), haloperidol (smd=0.27, 95% ci: 0.14-0.39), quetiapine (smd=0.25, 95% ci: 0.12-0.38), aripiprazole (smd=0.16, 95% ci: 0.04-0.28) and risperidone (smd=0.12, 95% ci: 0.03-0.21). |
2023-05-10 |
2023-08-14 |
human |
| Malgorzata Zaremba, Pawel Serafin, Patrycja Kleczkowsk. Antipsychotic Drugs Efficacy in Dextromethorphan-Induced Psychosis. Biomedicines. vol 11. issue 1. 2023-01-21. PMID:36672631. |
atypical neuroleptics (i.e., olanzapine, risperidone, quetiapine) and typical haloperidol have been used in symptomatic treatment due to their efficacy, especially in positive symptoms (hallucinations and delusions). |
2023-01-21 |
2023-08-14 |
Not clear |
| Patrick Vincent Marloth, Martin Riis Ladefoged, Magnus Spangsberg Boese. [Neuroleptic malignant syndrome caused by olanzapine, risperidone and haloperidol]. Ugeskrift for laeger. vol 184. issue 45. 2022-11-08. PMID:36345898. |
[neuroleptic malignant syndrome caused by olanzapine, risperidone and haloperidol]. |
2022-11-08 |
2023-08-14 |
Not clear |
| Patrick Vincent Marloth, Martin Riis Ladefoged, Magnus Spangsberg Boese. [Neuroleptic malignant syndrome caused by olanzapine, risperidone and haloperidol]. Ugeskrift for laeger. vol 184. issue 45. 2022-11-08. PMID:36345898. |
this is a case report of a 27-year-old man who developed neuroleptic malignant syndrome after administration of olanzapine, risperidone and haloperidol. |
2022-11-08 |
2023-08-14 |
Not clear |
| Jana Osacka, Alexander Kiss, Zuzana Bacova, Andrej Tillinge. Effect of Haloperidol and Olanzapine on Hippocampal Cells' Proliferation in Animal Model of Schizophrenia. International journal of molecular sciences. vol 23. issue 14. 2022-07-27. PMID:35887056. |
effect of haloperidol and olanzapine on hippocampal cells' proliferation in animal model of schizophrenia. |
2022-07-27 |
2023-08-14 |
Not clear |
| Jana Osacka, Alexander Kiss, Zuzana Bacova, Andrej Tillinge. Effect of Haloperidol and Olanzapine on Hippocampal Cells' Proliferation in Animal Model of Schizophrenia. International journal of molecular sciences. vol 23. issue 14. 2022-07-27. PMID:35887056. |
haloperidol (hal) and olanzapine (ola), commonly prescribed antipsychotics for schizophrenia treatment, affect neurogenesis too. |
2022-07-27 |
2023-08-14 |
Not clear |
| Meng He, Jun Fan, Ruqin Zhou, Guanbin Gao, Ruoxi Li, YuFeng Zuo, Benben Li, Yanmei Li, Taolei Su. NLRP3/Caspase-1-Mediated Pyroptosis of Astrocytes Induced by Antipsychotics Is Inhibited by a Histamine H1 Receptor-Selective Agonist. Frontiers in aging neuroscience. vol 14. 2022-05-26. PMID:35615587. |
twenty-four hour treatment with olanzapine, quetiapine, risperidone, or haloperidol dose-dependently increased the protein expression of astrocytic nlrp3, nlrp6, caspase-1, caspase-4, and gsdmd. |
2022-05-26 |
2023-08-13 |
Not clear |
| Meng He, Jun Fan, Ruqin Zhou, Guanbin Gao, Ruoxi Li, YuFeng Zuo, Benben Li, Yanmei Li, Taolei Su. NLRP3/Caspase-1-Mediated Pyroptosis of Astrocytes Induced by Antipsychotics Is Inhibited by a Histamine H1 Receptor-Selective Agonist. Frontiers in aging neuroscience. vol 14. 2022-05-26. PMID:35615587. |
co-treatment with a histamine h1 receptor agonist, 2-(3-trifluoromethylphenyl) histamine (fmph), dose-dependently reduced the increased expression of nlrp3, caspase-1 and gsdmd induced by olanzapine, quetiapine, risperidone, or haloperidol. |
2022-05-26 |
2023-08-13 |
Not clear |
| Leah Waldman, Brittany Richardson, John Hamilton, Panayotis Thano. Chronic Oral Olanzapine Treatment but not Haloperidol Decreases [ Neuroscience letters. 2022-04-28. PMID:35483503. |
chronic oral olanzapine treatment but not haloperidol decreases [ haloperidol and olanzapine are first and second-generation antipsychotic (neuroleptic) medications approved to treat schizophrenia. |
2022-04-28 |
2023-08-13 |
rat |
| Xiao-Juan Lyu, Adrian David Kan, Poh-Heng Chong, Keegan Lin, Yung-Hua Koh, Zhi-Zheng Ye. An open-label clinical trial of oral transmucosal haloperidol and oral transmucosal olanzapine in the treatment of terminal delirium at home. Trials. vol 23. issue 1. 2022-04-15. PMID:35422053. |
an open-label clinical trial of oral transmucosal haloperidol and oral transmucosal olanzapine in the treatment of terminal delirium at home. |
2022-04-15 |
2023-08-13 |
Not clear |
| Michael Spedding, Claude Sebban, Thérèse M Jay, Cyril Rocher, Brigitte Tesolin-Decros, Paul Chazot, Esther Schenker, Gabor Szénási, György I Lévay, Katalin Megyeri, Jozsef Barkóczy, Laszlo G Hársing, Ian Thomson, Mark O Cunningham, Miles A Whittington, Lori-An Etherington, Jeremy J Lambert, Ferenc A Antoni, Istvan Gacsály. Phenotypical Screening on Neuronal Plasticity in Hippocampal-Prefrontal Cortex Connectivity Reveals an Antipsychotic with a Novel Profile. Cells. vol 11. issue 7. 2022-04-12. PMID:35406745. |
egis 11150 enhanced h-pfc coherence, and increased the 8-9 hz theta band of the eeg power spectrum (from 0.002 mg/kg i.p, at >30× lower doses than clozapine, and >100× for olanzapine, risperidone, or haloperidol). |
2022-04-12 |
2023-08-13 |
Not clear |
| Konstantinos N Fountoulakis, Stephen M Stah. The effect of first- and second-generation antipsychotics on brain morphology in schizophrenia: A systematic review of longitudinal magnetic resonance studies with a randomized allocation to treatment arms. Journal of psychopharmacology (Oxford, England). 2022-04-09. PMID:35395911. |
a fourth was published later; they included 359 subjects, of whom 86 were healthy controls, while the rest were first-episode patients, with 91 under olanzapine, 93 under haloperidol, 48 under risperidone, 5 under paliperidone, 6 under ziprasidone, and 30 under placebo. |
2022-04-09 |
2023-08-13 |
human |
| Heidi N Boyda, Michelle Pham, Joyce Huang, Amanzo A Ho, Ric M Procyshyn, Jessica W Y Yuen, William G Honer, Alasdair M Bar. Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance. Frontiers in pharmacology. vol 13. 2022-03-04. PMID:35242029. |
plasma catecholamines were also increased by drug treatment, with greatest effects for norepinephrine and epinephrine caused by clozapine > risperidone > olanzapine > haloperidol. |
2022-03-04 |
2023-08-13 |
rat |